Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Der Nervenarzt
|
May 1, 1994
[Comprehension of metaphoric speech by healthy probands and schizophrenic patients. An experimental psychopathologic contribution to concretism]
M Spitzer, M Lukas, S Maier, et al.
Pharmacopsychiatry
|
July 1, 1987
Neuroleptic malignant syndrome: observations on altered consciousness
G Deuschl, G Oepen, L Hermle, et al.
Psychiatrische Praxis
|
January 1, 1992
[Clinical and laboratory differentiation of alcohol withdrawal syndrome ("predelirium") and alcoholic delirium]
A Jost, L Hermle, M Spitzer, et al.
Fortschritte Der Neurologie-Psychiatrie
|
October 1, 1992
[Relations of model and drug-induced psychoses to schizophrenic diseases]
L Hermle, M Spitzer, D Borchardt, et al.
Pharmacopsychiatry
|
October 1, 1998
History, rationale and potential of human experimental hallucinogenic drug research in psychiatry
E Gouzoulis-Mayfrank, L Hermle, B Thelen, et al.
Fortschritte Der Neurologie-Psychiatrie
|
May 31, 2008
[Hallucinogen-induced psychological disorders]
L Hermle, K-A Kovar, W Hewer, et al.
Pharmazie in Unserer Zeit
|
May 1, 1990
[Synthetic drugs of abuse, the second generation (designer drugs). 1. Amphetamine and other arylalkane amines]
K A Kovar, C Rösch, A Rupp, et al.
Schizophrenia Research
|
December 15, 1996
The Stroop effect in schizophrenic patients
H H Hepp, S Maier, L Hermle, et al.
Psychiatry Research
|
September 1, 1989
Right hemisphere involvement in mescaline-induced psychosis
G Oepen, M Fuenfgeld, A Harrington, et al.
Biological Psychiatry
|
December 15, 1992
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers
E Gouzoulis, A Steiger, M Ensslin, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Der Nervenarzt
|
May 1, 1994
[Comprehension of metaphoric speech by healthy probands and schizophrenic patients. An experimental psychopathologic contribution to concretism]
M Spitzer, M Lukas, S Maier, et al.
Pharmacopsychiatry
|
July 1, 1987
Neuroleptic malignant syndrome: observations on altered consciousness
G Deuschl, G Oepen, L Hermle, et al.
Psychiatrische Praxis
|
January 1, 1992
[Clinical and laboratory differentiation of alcohol withdrawal syndrome ("predelirium") and alcoholic delirium]
A Jost, L Hermle, M Spitzer, et al.
Fortschritte Der Neurologie-Psychiatrie
|
October 1, 1992
[Relations of model and drug-induced psychoses to schizophrenic diseases]
L Hermle, M Spitzer, D Borchardt, et al.
Pharmacopsychiatry
|
October 1, 1998
History, rationale and potential of human experimental hallucinogenic drug research in psychiatry
E Gouzoulis-Mayfrank, L Hermle, B Thelen, et al.
Fortschritte Der Neurologie-Psychiatrie
|
May 31, 2008
[Hallucinogen-induced psychological disorders]
L Hermle, K-A Kovar, W Hewer, et al.
Pharmazie in Unserer Zeit
|
May 1, 1990
[Synthetic drugs of abuse, the second generation (designer drugs). 1. Amphetamine and other arylalkane amines]
K A Kovar, C Rösch, A Rupp, et al.
Schizophrenia Research
|
December 15, 1996
The Stroop effect in schizophrenic patients
H H Hepp, S Maier, L Hermle, et al.
Psychiatry Research
|
September 1, 1989
Right hemisphere involvement in mescaline-induced psychosis
G Oepen, M Fuenfgeld, A Harrington, et al.
Biological Psychiatry
|
December 15, 1992
Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers
E Gouzoulis, A Steiger, M Ensslin, et al.
Page
of 6